We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:NGNE
​
​
logo

Neurogene Inc. (NGNE)

Nasdaq • NGNE • US64135M1053

25.31Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 22, 2026, ORTEX estimated 44.1% of free float sold short, 15.4 days to cover, cost to borrow 0.39%. Sign up for live short interest data.

Market Cap

506m USD | # 5945 in US

Volume

302.85k shares | 9.46m USD

Shares Outstanding

20.01m

Free Float Shares

56.47% | 11.3m

DB:UU8

News

NGNE key data

Neurogene Inc. (Nasdaq: NGNE) has a market capitalization of $506.49M. Last close $25.31 (as of 2026-11-09); 52-week range $15.93 to $43.66. ORTEX data as of 2026-10-22: short interest was 44.07% of free float, 15.4 days to cover and the average cost to borrow was 0.39%. Sign up for live short interest data.

  • NGNE news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.